Is it still worth pursuing the repurposing of metformin as a cancer ...

Interest in metformin for cancer treatment is declining due to disappointing trial results. However, new research suggests potential in targeting mitochondrial metabolism, altering gut microbiota, and enhancing immunotherapy. Metformin may also prevent cancer in high-risk groups, supported by early clinical data. Future studies should focus on well-designed trials in selected populations.